These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 9916925)
21. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression. Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057 [TBL] [Abstract][Full Text] [Related]
22. Deregulated expression of p27(Kip1) in human breast cancers. Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577 [TBL] [Abstract][Full Text] [Related]
23. Analysis of intratumoral heterogeneity and amplification status in breast carcinomas with equivocal (2+) HER-2 immunostaining. Lewis JT; Ketterling RP; Halling KC; Reynolds C; Jenkins RB; Visscher DW Am J Clin Pathol; 2005 Aug; 124(2):273-81. PubMed ID: 16040300 [TBL] [Abstract][Full Text] [Related]
24. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Reifenberger G; Ichimura K; Reifenberger J; Elkahloun AG; Meltzer PS; Collins VP Cancer Res; 1996 Nov; 56(22):5141-5. PubMed ID: 8912848 [TBL] [Abstract][Full Text] [Related]
25. Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours. Butcher DT; Rodenhiser DI Eur J Cancer; 2007 Jan; 43(1):210-9. PubMed ID: 17071074 [TBL] [Abstract][Full Text] [Related]
26. Comparison of immunohistochemical and fluorescence in situ hybridization assessment for HER-2/neu status in Taiwanese breast cancer patients. Kuo SJ; Wang BB; Chang CS; Chen TH; Yeh KT; Lee DJ; Yin PL; Chen M Taiwan J Obstet Gynecol; 2007 Jun; 46(2):146-51. PubMed ID: 17638622 [TBL] [Abstract][Full Text] [Related]
27. Differential loss of heterozygosity profile on chromosome 3p in ductal and lobular breast carcinomas. de Oliveira MM; de Oliveira SF; Lima RS; de Andrade Urban C; Cavalli LR; de Souza Fonseca Ribeiro EM; Cavalli IJ Hum Pathol; 2012 Oct; 43(10):1661-7. PubMed ID: 22503535 [TBL] [Abstract][Full Text] [Related]
28. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778 [TBL] [Abstract][Full Text] [Related]
29. Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma. Zhu XL; Hartwick W; Rohan T; Kandel R Mod Pathol; 1998 Nov; 11(11):1082-8. PubMed ID: 9831206 [TBL] [Abstract][Full Text] [Related]
30. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma. Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P Breast J; 2005; 11(4):278-80. PubMed ID: 15982396 [TBL] [Abstract][Full Text] [Related]
31. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc. Pawar SA; Szentirmay MN; Hermeking H; Sawadogo M Oncogene; 2004 Aug; 23(36):6125-35. PubMed ID: 15208653 [TBL] [Abstract][Full Text] [Related]
32. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors. Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847 [TBL] [Abstract][Full Text] [Related]
33. BRCA-associated breast cancer: absence of a characteristic immunophenotype. Robson M; Rajan P; Rosen PP; Gilewski T; Hirschaut Y; Pressman P; Haas B; Norton L; Offit K Cancer Res; 1998 May; 58(9):1839-42. PubMed ID: 9581822 [TBL] [Abstract][Full Text] [Related]
34. Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer. Choschzick M; Lebeau A; Marx AH; Tharun L; Terracciano L; Heilenkötter U; Jaenicke F; Bokemeyer C; Simon R; Sauter G; Schwarz J Hum Pathol; 2010 Mar; 41(3):358-65. PubMed ID: 19896697 [TBL] [Abstract][Full Text] [Related]
35. Cyclin D1 overexpression in invasive breast cancers: correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity. Takano Y; Takenaka H; Kato Y; Masuda M; Mikami T; Saegusa M; Okayasu I J Cancer Res Clin Oncol; 1999; 125(8-9):505-12. PubMed ID: 10480344 [TBL] [Abstract][Full Text] [Related]
36. Correlations of TOP2A gene aberrations and expression of topoisomerase IIα protein and TOP2A mRNA expression in primary breast cancer: a retrospective study of 86 cases using fluorescence in situ hybridization and immunohistochemistry. Meng H; Chen R; Li W; Xu L; Xu L Pathol Int; 2012 Jun; 62(6):391-9. PubMed ID: 22612507 [TBL] [Abstract][Full Text] [Related]
37. [Amplification and overexpression of c-erbB2 in human breast cancer]. Chen Y; Dong J; Li C Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):16-9. PubMed ID: 7656779 [TBL] [Abstract][Full Text] [Related]
38. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws. Lopes MA; Nikitakis NG; Ord RA; Sauk J Oral Oncol; 2001 Oct; 37(7):566-71. PubMed ID: 11564577 [TBL] [Abstract][Full Text] [Related]
39. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Sonoda Y; Yoshimoto T; Sekiya T Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535 [TBL] [Abstract][Full Text] [Related]
40. CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons. Wei G; Lonardo F; Ueda T; Kim T; Huvos AG; Healey JH; Ladanyi M Int J Cancer; 1999 Jan; 80(2):199-204. PubMed ID: 9935200 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]